Annual Working Capital
$16.06 M
-$18.93 M-54.10%
December 31, 2023
Summary
- As of February 8, 2025, CMMB annual working capital is $16.06 million, with the most recent change of -$18.93 million (-54.10%) on December 31, 2023.
- During the last 3 years, CMMB annual working capital has risen by +$5.54 million (+52.61%).
- CMMB annual working capital is now -73.25% below its all-time high of $60.04 million, reached on December 31, 2021.
Performance
CMMB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$15.54 M
+$6.40 M+69.92%
September 1, 2024
Summary
- As of February 8, 2025, CMMB quarterly working capital is $15.54 million, with the most recent change of +$6.40 million (+69.92%) on September 1, 2024.
- Over the past year, CMMB quarterly working capital has increased by +$6.40 million (+69.92%).
- CMMB quarterly working capital is now -76.69% below its all-time high of $66.68 million, reached on June 30, 2021.
Performance
CMMB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CMMB Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.1% | +69.9% |
| 3 y3 years | +52.6% | +69.9% |
| 5 y5 years | +52.6% | +69.9% |
CMMB Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.3% | at low | -74.1% | +69.9% |
| 5 y | 5-year | -73.3% | +52.6% | -76.7% | +69.9% |
| alltime | all time | -73.3% | +52.6% | -76.7% | +69.9% |
Chemomab Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.54 M(+69.9%) |
| Jun 2024 | - | $9.15 M(-26.5%) |
| Mar 2024 | - | $12.44 M(-22.5%) |
| Dec 2023 | $16.06 M(-54.1%) | $16.06 M(-23.1%) |
| Jun 2023 | - | $20.88 M(-22.0%) |
| Mar 2023 | - | $26.78 M(-23.5%) |
| Dec 2022 | $34.99 M | $34.99 M(-19.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $43.25 M(-14.3%) |
| Jun 2022 | - | $50.44 M(-9.7%) |
| Mar 2022 | - | $55.82 M(-7.0%) |
| Dec 2021 | $60.04 M(+470.5%) | $60.04 M(-6.5%) |
| Sep 2021 | - | $64.21 M(-3.7%) |
| Jun 2021 | - | $66.68 M(+21.5%) |
| Mar 2021 | - | $54.89 M(+421.6%) |
| Dec 2020 | $10.52 M | $10.52 M |
FAQ
- What is Chemomab Therapeutics annual working capital?
- What is the all time high annual working capital for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual working capital year-on-year change?
- What is Chemomab Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Chemomab Therapeutics?
- What is Chemomab Therapeutics quarterly working capital year-on-year change?
What is Chemomab Therapeutics annual working capital?
The current annual working capital of CMMB is $16.06 M
What is the all time high annual working capital for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual working capital is $60.04 M
What is Chemomab Therapeutics annual working capital year-on-year change?
Over the past year, CMMB annual working capital has changed by -$18.93 M (-54.10%)
What is Chemomab Therapeutics quarterly working capital?
The current quarterly working capital of CMMB is $15.54 M
What is the all time high quarterly working capital for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly working capital is $66.68 M
What is Chemomab Therapeutics quarterly working capital year-on-year change?
Over the past year, CMMB quarterly working capital has changed by +$6.40 M (+69.92%)